Big cargo gene therapy
With a proven track record in biopharmaceuticals, we aim to revolutionize advanced gene therapy to address unmet patient needs.
Cancers and liver diseases
We aim to create best-in-class bacteria-based therapies for unmet patient needs. Our current therapeutic focus includes pancreatic cancer, colorectal cancer, cervical cancer and liver diseases, while we continue to seek new medical applications. Preclinical research collaborations with pharma & biotech companies are an important pillar of our strategy.
Redbiotec News
Gene therapy expert Dr. Michele Calos joins the Scientific Advisory Board of Redbiotec
Redbiotec AG, a pioneer in living medicines, further expands its Scientific Advisory Board with the appointment of Professor Michele Calos, [...]
Redbiotec expands its Scientific Advisory Board with the appointment of Prof. Dr. Dr. Christoph U. Schoen
Redbiotec AG, a pioneer in living medicines, is pleased to announce the addition of Professor Christoph U. Schoen, MD, PhD [...]
Redbiotec expands its expertise – two new appointments
Redbiotec welcomes two new senior people: Dr. Jin Huh, a synthetic biology expert from the Massachusetts Institute of Technology (MIT) [...]
Collaboration with LOVIT/ Dr. Antonio Marchini
Redbiotec is pleased to announce the appointment of Dr. Antonio Marchini, head of Laboratory of Oncolytic-Virus-Immuno-Therapeutics (LOVIT) at the Luxembourg Institute [...]